Variability in Hemoglobin Levels and the Factors Associated with Mortality in Hemodialysis Patients: A 78-Month Follow-Up Study

Some studies have described that when the hemoglobin levels of chronic kidney disease (CKD) patients change, especially in those taking erythropoiesis-stimulating agents (ESA), they are associated with unfavorable outcomes such as increased morbidity and mortality, mainly due to cardiovascular event...

Descripción completa

Detalles Bibliográficos
Autores principales: Salgado Filho, Natalino, Lages, Joyce Santos, Brito, Dyego José de Araújo, Santos, Elton John Freitas, dos Santos, Alcione Miranda, de Souza, Francival Leite, Mendes, Vinícius Giuliano Gonçalves, Silva, Giselle Andrade dos Santos, Carneiro, Erika Cristina Ribeiro de Lima, Muniz, Monique Pereira Rêgo, Silva, Gyl Eanes Barros, Sesso, Ricardo de Castro Cintra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908351/
https://www.ncbi.nlm.nih.gov/pubmed/33530448
http://dx.doi.org/10.3390/ijerph18031078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908351/
https://www.ncbi.nlm.nih.gov/pubmed/33530448
http://dx.doi.org/10.3390/ijerph18031078

Ejemplares similares